#Coronavirus Disease Research #References (by AMEDEO.com, June 22 ’24)


  1. Correction: Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19.
    Ann Intern Med. 2024 Jun 18. doi: 10.7326/ANNALS-24-00699.
    PubMed        


    Antiviral Res
  2. DICKEY TH, Salinas ND, Patel P, Orr-Gonzalez S, et al
    RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination.
    Antiviral Res. 2024 Jun 18:105937. doi: 10.1016/j.antiviral.2024.105937.
    PubMed         Abstract available


    BMJ
  3. MORGAN J
    “I wasn’t alone after all”-how modelling vulnerability can support staff wellbeing.
    BMJ. 2024;385:q1313.
    PubMed        
  4. ALKHALDI M
    Call to boost the profile of the Middle East and north Africa region in global health.
    BMJ. 2024;385:q1272.
    PubMed        
  5. LIMB M
    Election watch: How credible are the main parties’ pledges on the NHS?
    BMJ. 2024;385:q1320.
    PubMed        
  6. OXTOBY K
    Why I . . . go adventure sailing.
    BMJ. 2024;385:q1292.
    PubMed        
  7. IRWIN EM
    Knock, knock. Who’s there? It’s the senior house officers trying to come back . .
    BMJ. 2024;385:q1343.
    PubMed        
  8. POLKINGHORN A
    Thank you for waiting.
    BMJ. 2024;385:q1295.
    PubMed        
  9. FEINMANN J
    Analysis reveals global post-covid surge in infectious diseases.
    BMJ. 2024;385:q1348.
    PubMed        
  10. LAUNER J
    John Launer: Faces or candlesticks? Why we need continuity in teams.
    BMJ. 2024;385:q1323.
    PubMed        
  11. O’DOWD A
    World is woefully unprepared for another pandemic, experts warn.
    BMJ. 2024;385:q1355.
    PubMed        
  12. OLIVER D
    David Oliver: Will the actions pledged in Labour’s election manifesto save health and social care?
    BMJ. 2024;385:q1326.
    PubMed        
  13. BUSE K, McKee M
    UK political parties pledge to strengthen security-yet ignore health security.
    BMJ. 2024;385:q1359.
    PubMed        
  14. ENRIA L, Dwyer H, Marchant M, Beckmann N, et al
    Political dimensions of misinformation, trust, and vaccine confidence in a digital age.
    BMJ. 2024;385:e079940.
    PubMed        
  15. VISWANATH K, Lee EJ, Dryer E
    Communication inequalities and incomplete data hinder understanding of how social media affect vaccine uptake.
    BMJ. 2024;385:e076478.
    PubMed        
  16. FEINMANN J
    GP who confronted Rishi Sunak received “hundreds” of supportive messages from doctors.
    BMJ. 2024;385:q1375.
    PubMed        
  17. LIMB M
    Avoidable mortality in England and Wales remains higher than before pandemic, data show.
    BMJ. 2024;385:q1370.
    PubMed        
  18. IACOBUCCI G
    Junior doctors offer prime minister “final chance” to avoid pre-election strike.
    BMJ. 2024;385:q1367.
    PubMed        


    Int J Infect Dis
  19. FARMER G, Sikdar KC, Lo T, Conly J, et al
    Real-world evidence of sotrovimab effectiveness for preventing severe outcomes in patients with COVID-19: A quality improvement propensity matched retrospective cohort study of a pan-provincial program in Alberta, Canada.
    Int J Infect Dis. 2024 Jun 14:107136. doi: 10.1016/j.ijid.2024.107136.
    PubMed         Abstract available
  20. HUIBERTS AJ, van den Hof S, Knol MJ
    Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022.
    Int J Infect Dis. 2024 Jun 18:107127. doi: 10.1016/j.ijid.2024.107127.
    PubMed        


    J Infect
  21. MIKOLAJCZYK R, Diexer S, Klee B, Pfrommer L, et al
    Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO).
    J Infect. 2024 Jun 17:106206. doi: 10.1016/j.jinf.2024.106206.
    PubMed         Abstract available
  22. KAJIHARA T, Yahara K, Kamigaki T, Hirabayashi A, et al
    Effects of coronavirus disease 2019 on the spread of respiratory-transmitted human-to-human bacteria.
    J Infect. 2024 Jun 17:106201. doi: 10.1016/j.jinf.2024.106201.
    PubMed         Abstract available
  23. LIU B, Xu L, Ma Y, Wang H, et al
    Evidence of immunity gap: Decline in antibodies against M. pneumoniae during the COVID-19 pandemic.
    J Infect. 2024 Jun 18:106209. doi: 10.1016/j.jinf.2024.106209.
    PubMed        


    J Med Virol
  24. BLANGY-LETHEULE A, Vergnaud A, Dupas T, Habert D, et al
    Value of a secretomic approach for distinguishing patients with COVID-19 viral pneumonia among patients with respiratory distress admitted to intensive care unit.
    J Med Virol. 2024;96:e29756.
    PubMed         Abstract available
  25. ALMANZAR G, Koosha K, Vogt T, Stein A, et al
    Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2.
    J Med Virol. 2024;96:e29739.
    PubMed         Abstract available
  26. TANG Y, Zou X, Liu P, Dai Y, et al
    Human umbilical cord-derived mesenchymal stem cell transplantation improves the long COVID.
    J Med Virol. 2024;96:e29757.
    PubMed         Abstract available
  27. KARBIENER M, Kindle G, Meyts I, Seppanen MRJ, et al
    Clinical efficacy of SARS-CoV-2 Omicron-neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency.
    J Med Virol. 2024;96:e29738.
    PubMed         Abstract available
  28. ZHU W, Gu L
    Resurgence of seasonal influenza driven by A/H3N2 and B/Victoria in succession during the 2023-2024 season in Beijing showing increased population susceptibility.
    J Med Virol. 2024;96:e29751.
    PubMed         Abstract available


    J Virol
  29. CHEN Z, Cui Q, Ran Y, Achi JG, et al
    A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    J Virol. 2024 Jun 20:e0050424. doi: 10.1128/jvi.00504.
    PubMed         Abstract available
  30. STAHL-HENNIG C, Peter AS, Cordsmeier A, Stolte-Leeb N, et al
    Genetic barrier to resistance: a critical parameter for efficacy of neutralizing monoclonal antibodies against SARS-CoV-2 in a nonhuman primate model.
    J Virol. 2024 Jun 20:e0062824. doi: 10.1128/jvi.00628.
    PubMed         Abstract available
  31. PAN R, Li P, Meyerholz DK, Perlman S, et al
    Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.
    J Virol. 2024 Jun 18:e0058424. doi: 10.1128/jvi.00584.
    PubMed         Abstract available


    JAMA
  32. ZIMBROFF RM, Deardorff WJ, Song S, Nikolov MC, et al
    Use of a Financial Incentive Code for In-Home COVID-19 Vaccination of Homebound Older Adults.
    JAMA. 2024 Jun 20. doi: 10.1001/jama.2024.9673.
    PubMed        
  33. HARRIS E
    Lower Dose of Mpox Vaccine Was Safe, Effective.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8635.
    PubMed        
  34. HARRIS E
    Microneedle Vaccine Patches Generated Immune Response in Children.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8629.
    PubMed        


    Lancet
  35. ZAROCOSTAS J
    Mental health in emergencies requires “a major rethink”.
    Lancet. 2024;403:2582.
    PubMed        
  36. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed        
  37. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed        
  38. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed        
  39. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed        
  40. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed        


    N Engl J Med
  41. SAMET JH, El-Bassel N, Winhusen TJ, Jackson RD, et al
    Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
    N Engl J Med. 2024 Jun 16. doi: 10.1056/NEJMoa2401177.
    PubMed         Abstract available


    Nature
  42. LINDEBOOM RGH, Worlock KB, Dratva LM, Yoshida M, et al
    Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.
    Nature. 2024 Jun 19. doi: 10.1038/s41586-024-07575.
    PubMed         Abstract available
  43. ISRAELOW B, Iwasaki A
    First encounter with SARS-CoV-2: immune portraits of COVID susceptibility.
    Nature. 2024 Jun 19. doi: 10.1038/d41586-024-01644.
    PubMed        
  44. NURSE P
    We can make the UK a science superpower – with a radical political manifesto.
    Nature. 2024;630:532.
    PubMed        
  45. RIVA L, Yuan S, Yin X, Martin-Sancho L, et al
    Author Correction: Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
    Nature. 2024 Jun 18. doi: 10.1038/s41586-024-07659.
    PubMed        
  46. KULKARNI S
    AI and Euro 2024: VAR is shaking up football – and it’s not going away.
    Nature. 2024;630:538-539.
    PubMed        
  47. CASTELVECCHI D
    CERN’s $17-billion supercollider in question as top funder criticizes cost.
    Nature. 2024;630:539-540.
    PubMed        

Published by

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.